Stock Market & Financial Investment News

News Breaks October 2, 2012 08:44 EDT ROSG Rosetta Genomics announces U.S. launch of diagnostic tool Rosetta Genomics (ROSG) and privately held Precision Therapeutics announced the commercial launch of the miRview mets^2 assay in the U.S. oncology market. miRview mets^2 is a diagnostic tool for clinicians in the evaluation of their Cancer of Unknown/Uncertain Primary patients. News For ROSG From The Last 14 Days Check below for free stories on ROSG the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 15, 2013 15:03 EDT ROSG Rosetta Genomics volatility elevated into ASCO Subscribe for More Information May 10, 2013 08:31 EDT ROSG Rosetta Genomics receives full settlement payment from Sanra Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.